Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 1 Demographic characteristics

From: Early mortality in hip fracture patients admitted during first wave of the COVID-19 pandemic in Northern Italy: a multicentre study

Demographics

C+ (n = 53) m ± s (CI95)

C– (n = 424) m ± s (CI95)

p

Difference of the means (CI 95)

Age (mean ± SD)

83.3 ± 0.9 (83.05 to 83.55)

81.2 ± 0.5 (81.15 to 81.25)

0.156a

2.1 (2.26 to 1.94)

Sex, n (%)

  

0.044 a

 

 Male

5/53 (9%)

91 (21.5%)

  

 Female

48/53 (91%)

333 (78.5%)

  

CCI (mean ± SD)

6.0 ± 0.3 (5.92 to 6.08)

5.5 ± 0.1 (5.49 to 5.51)

0.093 a

0.5 (0.46 to 0.54)

 CCI ≥ 4, n (%)

47/53 (88.7%)

359 (84.6%)

  

CFS (mean ± SD)

5.3 ± 0.2 (5.24 to 5.36)

5.2 ± 0.1 (5.19 to 5.21)

0.612 a

0.1 (0.07 to 0.13)

 CFS ≥ 4, n (%)

42/53 (79%)

318 (75.0%)

  

ASA

2.7 ± 0.1 (2.67 to 2.73)

2.6 ± 0.1 (2.59 to 2.61)

0.427 a

 

Median (mode, IQR25–75)

3 (3; 2–4)

3 (3; 2–4)

0.2 b

 

 ASA = 1, n (%)

1/52 (2%)

9/370 (2%)

  

 ASA = 2, n (%)

19/52 (37%)

152/370 (41%)

  

 ASA = 3, n (%)

27/52 (51%)

184/370 (50%)

  

 ASA = 4, n (%)

5/52 (10%)

25/370 (7%)

  

 ASA = 5, n (%)

0/52 (0%)

0 /370 (0%)

  

 ASA = 6, n (%)

0/52 (0%)

0/370 (0%)

  

 ASA = n.a. (%)

1/53 (2%)

54/424 (13%)

  
  1. m: mean of the sample; s: standard deviation of the sample; CI95: confidence interval (95%). IQR25–75: inter-quartile range, from 25 to 75%; n.a.: not available data
  2. C+: patients with COVID-19; C−: control group; see definitions in Materials and methods
  3. aheteroscedastic two-tailed t-test
  4. bMann–Whitney test